These data suggest that the loss of RSK2 leading to CLS and neuronal deficits is related to defects in neuronal growth due to impaired RSK2-dependent PLD1 activity following NGF stimulation. This evidence concerns the gene RPS6KA3 and Coffin-Lowry syndrome.